SOPHiA GENETICS SA - Ordinary Shares (SOPH)

  Sophia Genetics (NASDAQ:SOPH) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

SOPH stock results show that Sophia Genetics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

CoreWeave, a company backed by Nvidia, is preparing to go public in 2025.

SOPH stock results show that Sophia Genetics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Shares of CrowdStrike Holdings, Inc. (NASDAQ: CRWD) shares surged 24.4% to $370.27 in pre-market trading after the company reported better-than-expected fourth-quarter earnings and revenues and issued upbeat guidance for FY25.

Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.

We're starting Wednesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on this morning!

U.S. stock futures were higher this morning, with the Nasdaq futures gaining by around 100 points on Wednesday.

As of Jan. 22, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.

Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

Gainers

  On Wednesday, 283 companies set new 52-week lows.